SIMPLY WALL St : Resultados PHARMAMAR del Tercer Trimestre de 2025 : Pérdida de 0,23 € Por Acción . Ingresos : 35,7 MILLONES de euros ( un 22 % Menos Que en el Tercer Trimestre de 2024 ) . Pérdida Neta : 4,10 MILLONES de euros ( un 205 % Menos Que las Ganancias del Tercer Trimestre de 2024 ) .
16 abril 2008
PharmaMar Farmaco Preclinico con actividad en Cancer de Pulmon y Colon .
Cytotoxic-Antineoplastic Derivatives of Prenyl-1,2-naphthohydroquinone
Abstract
Several new prenyl-1,2-naphthohydroquinone derivatives have been prepared by chemical modifications of Diels-Alder products which were obtained from cycloaddition of -myrcene to 1,2-benzoquinone and then evaluated in vitro for their cytotoxic activity against A-549 lung carcinoma, HT-29 colon carcinoma, and MB-231 breast adeno-carcinoma culture cells. Most of them exhibited GI50 values in the M-concentration level.
Abstract
Several new prenyl-1,2-naphthohydroquinone derivatives have been prepared by chemical modifications of Diels-Alder products which were obtained from cycloaddition of -myrcene to 1,2-benzoquinone and then evaluated in vitro for their cytotoxic activity against A-549 lung carcinoma, HT-29 colon carcinoma, and MB-231 breast adeno-carcinoma culture cells. Most of them exhibited GI50 values in the M-concentration level.
Suscribirse a:
Comentarios (Atom)
